Protective benefits are evidenced in the liver, GI tract, cardiovascular system, and nervous system [6, 11, 25]
Critically, AOD-9604 did not produce the metabolic side effects associated with full-length growth hormone, including no insulin resistance or glucose intolerance, no elevation of IGF-1 levels, no fluid retention or joint pain, and no cardiovascular parameter changes
All claims can be submitted by email to [email protected]
Oral and injectable administration worked equally well
In this week's Smart Medicine Evidence Substack Update, I break down: What the committee actually recommended Why this matters What physicians and patients need to know today Why the sciencenot the headlinesshould guide clinical decisions The link to my latest Smart Medicine Substack is in the first comment
All products are provided with documentation supporting quality and purity standards